NCI Community Oncology Research Program (NCORP)

The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.

The DCP Community Oncology and Prevention Trials Research Group administers this program.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

About NCORP

The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.

Visit the NCORP Website

Grantee Details

No matching Grants were found.

View All Grants

Clinical Trials

Title	Intervention	Sponsor Sort descending	Status
Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy	Best Practice, Quality-of-Life Assessment, Questionnaire Administration, Wound Dressing Material	Alliance for Clinical Trials in Oncology	Active, not recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer	Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration	Alliance for Clinical Trials in Oncology	Active, not recruiting
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer	therapeutic conventional surgery, whole breast irradiation	Alliance for Clinical Trials in Oncology	Completed
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer	Hypofractionated Radiation Therapy, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy	Alliance for Clinical Trials in Oncology	Active, not recruiting
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection	Axillary Lymph Node Dissection, Isosulfan Blue, Mapping, Quality-of-Life Assessment, Questionnaire Administration	Alliance for Clinical Trials in Oncology	Active, not recruiting
Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ	MRI, conventional surgery, letrozole	Alliance for Clinical Trials in Oncology	Completed
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy	Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Ondansetron Hydrochloride, Palonosetron Hydrochloride, Placebo	Alliance for Clinical Trials in Oncology	Completed
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	zoledronic acid	Alliance for Clinical Trials in Oncology	Completed
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer	Oxybutynin Chloride, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration	Alliance for Clinical Trials in Oncology	Completed
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer	Fulvestrant, Letrozole, Palbociclib, Quality-of-Life Assessment, Questionnaire Administration	Alliance for Clinical Trials in Oncology	Active, not recruiting